Table 4.
Outcomes of liver function tests for mice from the uninfected control, untreated control and treated groups MBZ-1% tragacanth and MBZ-OS (10 mice per group)
| Parameters | Definitions | Units | Uninfected control | Untreated control | MBZ-1% tracangth | MBZ-OS |
|---|---|---|---|---|---|---|
| T-BIL | Total bilirubin | umol/L | 2.3 (0.8) | 2.8 (0.4) | 3.2* (0.8) | 2.9 (0.5) |
| D-BIL | Direct bilirubin | umol/L | 0.5 (0.3) | 0.3 (0.1) | 0.4 (0.2) | 0.3 (0.1) |
| I-BIL | Indirect bilirubin | umol/L | 1.8** (0.7) | 2.6* (0.4) | 2.8* (0.7) | 2.6* (0.5) |
| TP | Total protein | g/L | 55.2 (1.9) | 57.7 (2.9) | 58.2 (3.8) | 63.1** (3.2) |
| ALB | Albumin | g/L | 31.6 (1.7) | 32.2 (1.6) | 32.7 (2.0) | 34.8 (2.0) |
| GLB | Globulin | g/L | 23.6 (0.8) | 25.6 (3.3) | 25.5 (3.0) | 28.3** (2.4) |
| A/G | 1.3 (0.1) | 1.3 (0.2) | 1.3 (0.2) | 1.2 (0.4) | ||
| AST | Aspartate transaminase | U/L | 122.8** (32.1) | 173.7* (107.0) | 113.9** (16.9) | 100.8** (14.7) |
| ALT | Alanine transaminase | U/L | 45.1** (21.8) | 81.0* (48.8) | 35.7 ** (17.7) | 27.6 ** (4.5) |
| AST/ALT | 3.0 (0.8) | 2.3 (0.7) | 3.6 ** (1.2) | 3.7** (0.7) | ||
| ALP | Alkaline phosphatase | U/L | 86.2 (29.6) | 67.4 (14.0) | 74.5 (28.8) | 80.7 (19.1) |
*P < 0.05 vs. uninfected group.
**P < 0.05 vs. untreated control group.